This section features information on all TRANSCAN funded projects by country and funding organization. Click on a country/funding organization to find out what projects have been financed by a specific country/funding organization.
Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors
Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia
An integrated European platform to conduct translational studies in myelodysplastic syndromes based on the EuroBloodNet infrastructure
Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets
Advancing liquid biopsies for monitoring and personalized treatment of children with neuroblastomas
Comprehensive genomic characterization of upper urinary tract urothelial carcinoma and paired bladder recurrences
Establishing an algorithm for the early diagnosis and follow-up of patients with pancreatic neuroendocrine tumors
Predictive models of therapy response in pancreatic neuroendocrine tumors
Profiling radioREsistant Differentiated thyroid Cancer: genes, immunity, cancer stem cells and epithelial-mesenchymal transition
Automated, absolute quantification of MRD in ALL patients by droplet microfluidics, single DNA copy barcoding and IG/TR amplicon NGS
Anti-PD1 and Niraparib (PARPi) combination therapy in gynae carcinosarcoma: Identification of response-predictive biomarkers and resistance mechanisms
A TranslatiOnal Platform for de-orphaning malignant pleural MESOthelioma
Airborne biomarkers for colorectal cancers
Biomarkers for diagnosis and prognosis of endometrial carcinoma
Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection
Detection of early esophageal cancer by near-infrared fluorescence molecular endoscopy
Multi-parametric analysis of the evolution and progression of low grade glioma
Single-cell immunophenotypic and transcriptomic profiling for minimally-invasive detection of early multiple myeloma
New strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles
Employing NGS technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients
Early detection of prostate cancer by liquid biopsies
Exploitation of extracellular vesicles for precision diagnostics of prostate cancer
Non-invasive prognostic markers for Resected Early-STage NSCLC: role of circulatING and exosomal miRNAs and free circulating DNA
Microbiota-based SCReening of Anal Cancer in HIV-infected individuals
Early detection of relapses in stage III colon cancer patients by longitudinally following a personalized molecular signature from a a blood test: THRuST
Integration of genetic biomarkers and early minimal residual disease to improve risk stratification and cure in childhood Acute Lymphoblastic Leukemia
Impact of dietary intervention on tumor immunity
Dual epigenetic targeting and immunotherapy to fight against cancer
Mutated neo-antigens in hepatocellular carcinoma
Deciphering immune response against glioblastoma to find new targets
Targeting sphingolipid metabolism to improve anti-melanoma immunotherapy
Approaching recurrence and resistance mechanisms in esophagogastric adenocarcinomas from the prospective MEMORI trial
Subscribe to our Newsletter You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter.
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 964264.
Legal Notice | Privacy Policy